Targeting DNA repair proteins: a promising avenue for cancer gene therapy

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Enhanced DNA repair in cancer cells correlates with treatment resistance and poor prognosis.
• DNA double-strand breaks (DSBs) are highly toxic DNA lesions induced by radio/chemotherapy.
• Efficient repair of DSBs is critical for cancer cell survival and genomic stability.

Purpose of the Study:

• To review gene therapy strategies targeting proteins involved in DSB repair.
• To explore the potential of reducing cancer cell DSB repair capacity to enhance treatment sensitivity.
• To discuss the clinical applicability of targeting DSB repair pathways.

Main Methods:

• Review of existing literature on gene therapy approaches for DSB repair inhibition.
• Analysis of in vitro and in vivo experimental results from studies targeting DSB repair proteins.
• Discussion of protein candidates and gene therapy strategies employed.

Main Results:

• Several protein candidates involved in DSB repair have been targeted by gene therapy.
• In vitro and in vivo studies demonstrate the potential of these strategies.
• Targeting DSB repair can reduce cancer cell survival and sensitize tumors to therapy.

Conclusions:

• Down-regulating or inactivating DSB repair proteins via gene therapy is a promising strategy.
• This approach holds potential for sensitizing tumors to radio/chemotherapy.
• Further research and clinical trials are warranted to translate these findings.